Skip to main content

Table 3 SEPT9 promoter methylation and 3-gene panel sensitivity values for CRC detection according with location, stage and CIMP and MSI status

From: A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway

Diagnosis group

SEPT9

SEPT9, MGMT, RASSF1A

Location

 Colon

84.0 (79/94)

95.7 (90/94)

 Proximal

86.7 (26/30)

93.3 (28/30)

 Distal

82.8 (53/64)

96.9 (62/64)

 Rectum

88.2 (45/51)

98.0 (50/51)

Stage

 Stage I and II

91.4 (32/35)

100 (35/35)

 Stage III

80.0 (28/35)

94.2 (33/35)

 Stage IV

84.9 (62/73)

95.9 (70/73)

CIMP

 CIMP-negative

85.5 (112/131)

96.9 (127/131)

 CIMP-positive

90.9 (10/11)

100 (11/11)

MSI

 MSI-L/MSS

85.4 (117/137)

97.1 (133/137)

 MSI-H

87.5 (7/8)

87.5 (7/8)

  1. CIMP CpG island methylator phenotype, MSI microsatellite instability, MSI-H MSI high, MSI-L MSI low, MSS microsatellite stable, n number of positive cases, N total of cases in each group